ResearcherNavarre Institute of Health ResearchActive in the last 2 years
Fernando Rotellar
Matched on ORCID iD 0000-0002-6557-0712; OpenAlex author ID A5006228374. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper
Papers 7
- Surgical treatment of liver metastasis from pancreatic cancer. Co-author DOI 10.1016/j.suronc.2025.102308↗
- Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gassur.2024.01.018↗
- Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials. Last author DOI 10.1093/bjsopen/zrae087↗
- Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2023.03.001↗
- Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic adenocarcinoma. Last author DOI 10.17235/reed.2022.9256/2022↗
- Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse. Co-author DOI 10.3390/cancers11050606↗
- [Information for patients. Pancreatic cancer]. First author DOI 10.4321/s1130-01082012000700010↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Javier Rodríguez · 3 shared papers, 2019–2024 · strength 0.47
- Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087↗
- Paper Delays to surgery following chemoradiotherapy lead to poorer oncologic outcomes in patients with localized pancreatic a… DOI 10.17235/reed.2022.9256/2022↗
- Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
- Mariano Ponz‐Sarvisé · 3 shared papers, 2019–2024 · strength 0.45
- Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087↗
- Paper Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2023.03.001↗
- Paper Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk … DOI 10.3390/cancers11050606↗
- Mario Serradilla Martin · 2 shared papers, 2024–2025 · strength 0.34
- Gerardo Blanco‐Fernández · 2 shared papers, 2024–2025 · strength 0.34
- Javier A. Cienfuegos · 2 shared papers, 2012–2023 · strength 0.25
- Pablo Sala Elarre · 2 shared papers, 2019–2023 · strength 0.24
- Daniel Aliseda · 1 shared paper, 2024 · strength 0.21
- José Manuel Ramia · 1 shared paper, 2025 · strength 0.18
- Mar Achalandabaso Boira · 1 shared paper, 2025 · strength 0.18
- José Manuel Asencio · 1 shared paper, 2025 · strength 0.18
- Víctor López‐López · 1 shared paper, 2025 · strength 0.18
- Eva M. Montalbá Orón · 1 shared paper, 2025 · strength 0.18
- Marina Garcés‐Albir · 1 shared paper, 2024 · strength 0.16
- Silvia Carbonell‐Morote · 1 shared paper, 2024 · strength 0.16
- Luis Sabater-Orti · 1 shared paper, 2024 · strength 0.16
- José Manuel Ramia · 1 shared paper, 2024 · strength 0.16
- A. Vilalta · 1 shared paper, 2023 · strength 0.16
- Kenneth H. Yu · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.